You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 20, 2024

CLINICAL TRIALS PROFILE FOR RABAVERT


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for RABAVERT

Trial ID Title Status Sponsor Phase Start Date Summary
NCT02374814 ↗ Immunogenicity of Rabies Vaccine for Pre Exposure Prophylaxis Completed Walter Reed Army Institute of Research (WRAIR) Phase 4 2015-03-24 The purpose of this study is to compare the effectiveness of a two dose versus a three dose schedule and intramuscular versus intradermal injection for pre-exposure prophylaxis.
NCT02374814 ↗ Immunogenicity of Rabies Vaccine for Pre Exposure Prophylaxis Completed State University of New York - Upstate Medical University Phase 4 2015-03-24 The purpose of this study is to compare the effectiveness of a two dose versus a three dose schedule and intramuscular versus intradermal injection for pre-exposure prophylaxis.
NCT02564471 ↗ Effect of Antimalarial Drugs to Rabies Vaccine for Post-exposure Prophylaxis. Completed Kansas State University Phase 4 2016-11-11 This is an exploratory trial to evaluate the effect of antimalarial drugs on the immune response generated by rabies vaccine when administered for post-exposure prophylaxis. This study will use the FDA approved post-exposure prophylaxis vaccine regimen (without rabies immune globulin) in the presence or absence of an FDA-approved malaria chemoprophylaxis regimen.
NCT02564471 ↗ Effect of Antimalarial Drugs to Rabies Vaccine for Post-exposure Prophylaxis. Completed Walter Reed Army Institute of Research (WRAIR) Phase 4 2016-11-11 This is an exploratory trial to evaluate the effect of antimalarial drugs on the immune response generated by rabies vaccine when administered for post-exposure prophylaxis. This study will use the FDA approved post-exposure prophylaxis vaccine regimen (without rabies immune globulin) in the presence or absence of an FDA-approved malaria chemoprophylaxis regimen.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for RABAVERT

Condition Name

Condition Name for RABAVERT
Intervention Trials
Rabies 2
Healthy 1
Virus Diseases 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for RABAVERT
Intervention Trials
Rabies 4
Virus Diseases 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for RABAVERT

Trials by Country

Trials by Country for RABAVERT
Location Trials
United States 8
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for RABAVERT
Location Trials
New York 3
Maryland 1
Kansas 1
Florida 1
North Carolina 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for RABAVERT

Clinical Trial Phase

Clinical Trial Phase for RABAVERT
Clinical Trial Phase Trials
Phase 4 2
Phase 2/Phase 3 1
Phase 1 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for RABAVERT
Clinical Trial Phase Trials
Completed 3
Active, not recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for RABAVERT

Sponsor Name

Sponsor Name for RABAVERT
Sponsor Trials
Walter Reed Army Institute of Research (WRAIR) 2
State University of New York - Upstate Medical University 2
Kansas State University 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for RABAVERT
Sponsor Trials
Other 4
U.S. Fed 2
Industry 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.